Search for: "Life Sciences, Inc." Results 141 - 160 of 1,562
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Feb 2013, 4:00 pm by Amber Walsh
-based New Enterprise Associates (NEA), a venture capital firm that focuses on life sciences and other industries, and Novartis Venture Fund (NVF), which has a U.S. office in Cambridge, Mass., and invests in life science companies. [read post]
19 Aug 2015, 8:00 am by Debra A. McCurdy
In a post on our Life Sciences Legal Update blog here, we discuss the first judicial opinion interpreting the Affordable Care Act’s “60-Day Overpayment Rule” in a False Claims Act case, which was recently issued by the Southern District of New York. [read post]
11 Jul 2012, 10:22 am by Matthew Huisman
King & Spalding has added a partner to its Food and Drug Administration and life sciences practice, the firm announced Wednesday. [read post]
14 May 2020, 7:58 am by Renae Lloyd
It operates through the following business segments: Senior Housing Triple-Net, Senior Housing Operating Portfolio (SHOP), Life Science, and Medical Office. [read post]
4 Oct 2022, 9:15 am by Laura Smalley
The Federal Circuit’s denial of en banc rehearing and the Supreme Court’s denial of certiorari review mean the decision in American Axle & Manufacturing, Inc. v. [read post]
4 Oct 2022, 9:15 am by Laura Smalley
The Federal Circuit’s denial of en banc rehearing and the Supreme Court’s denial of certiorari review mean the decision in American Axle & Manufacturing, Inc. v. [read post]
4 Dec 2023, 10:00 pm by Sherica Celine
Watch now » Related Content Amgen Patent Ruling's Impact Extends Beyond Life Sciences Gain insight from Law360 expert analysis on the impacts of Amgen Inc. v. [read post]
20 Oct 2023, 9:04 am by Geoff Schweller
On October 17, the United States’ Attorney’s Office for the District of Massachusetts announced a False Claims Act settlement with Exagen Inc., a life sciences company that makes diagnostic tests for the treatment of autoimmune conditions. [read post]
30 Aug 2021, 8:11 am by Cinthia Macie
Federal Trade Commission on Tuesday said it seeks to unwind life science company Illumina Inc’s $7.1 billion acquisition of Grail Inc, alleging it would harm innovation and boost prices. [read post]
18 Jul 2011, 2:42 pm
The defendants of the California products liability case are Integra Life Sciences Holding Corp. and Miltex Inc. [read post]
24 Jan 2013, 6:51 am by David Jensen
Anne Marie Duliege , vice president of Affymax Michael Freidman, CEO City of Hope Michael Goldberg, executive chairman of Nodality, Inc., and DNAnexus, appointed as executive officer of a commercial life science entity Sam Hawgood, dean of the UC San Francisco medical school Steve Juelsgaard, former executive vice president of Genentech, appointed as executive officer of a commercial life science entity Sherry Lansing, chairwoman of the UC… [read post]
1 Mar 2023, 4:15 am by Ashley Sloat
This is a case that could have profound impacts both on the invention enablement issues that have been plaguing life science patenting, but also more broadly on defining the contemporary role that the patent system will play in our innovation economy going forward. [read post]
22 May 2013, 7:43 pm by Amber Walsh
F2 is a family of life science funds established by Morana Jovan-Embiricos Participation also came from the following existing investors: Biotech Growth N.V., MPM Capital, Brookside Capital, MPM Bio IV NVS Strategic Fund and BB Biotech Ventures. [read post]
3 Jan 2010, 9:48 pm by Patent Docs
January 6-10, 2010 - 27th Annual National CLE Conference (Law Education Institute, Inc.) - Vail, CO January 20-21, 2010 - Life Sciences IP Due Diligence (American Conference Institute) - New York, NY January 25-26, 2010 - European Pharmaceutical Regulatory Law Boot Camp (American Conference Institute) - New York, NY January 26-27, 2010 - Advanced In-House Counsel Forum on China IP Law (C5) - Shanghai, China January 27-30, 2010 - Mid-Winter Institute (American Intellectual… [read post]
1 Mar 2023, 4:15 am by Ashley Sloat
This is a case that could have profound impacts both on the invention enablement issues that have been plaguing life science patenting, but also more broadly on defining the contemporary role that the patent system will play in our innovation economy going forward. [read post]
27 Dec 2009, 8:02 pm by Patent Docs
January 6-10, 2010 - 27th Annual National CLE Conference (Law Education Institute, Inc.) - Vail, CO January 20-21, 2010 - Life Sciences IP Due Diligence (American Conference Institute) - New York, NY January 25-26, 2010 - European Pharmaceutical Regulatory Law Boot Camp (American Conference Institute) - New York, NY January 26-27, 2010 - Advanced In-House Counsel Forum on China IP Law (C5) - Shanghai, China January 27-28, 2010 - Pharma & Biotech Patent Litigation (C5)… [read post]
17 Jun 2018, 10:32 am
Theranos was purportedly a private health care and life sciences company seeking to revolutionize medi... [read post]
20 Dec 2009, 7:59 pm by Patent Docs
January 6-10, 2010 - 27th Annual National CLE Conference (Law Education Institute, Inc.) - Vail, CO January 20-21, 2010 - Life Sciences IP Due Diligence (American Conference Institute) - New York, NY January 25-26, 2010 - European Pharmaceutical Regulatory Law Boot Camp (American Conference Institute) - New York, NY January 26-27, 2010 - Advanced In-House Counsel Forum on China IP Law (C5) - Shanghai, China January 27-28, 2010 - Pharma & Biotech Patent Litigation (C5)… [read post]